Company Overview
Snapshot
Founded in February 2013, Luminera Derm operates with 11–50 employees. The company was acquired by Allergan Aesthetics in October 2020.
Business overview
Luminera Derm is an R&D company and manufacturer specializing in injectable medical devices for aesthetic medicine. The company develops products such as Crystalys, a calcium hydroxyapatite-based dermal filler, HArmonyCa for facial volume restoration, and Hydryalix and Hydryal, which are hyaluronic acid-based injectable fillers. Luminera Derm serves the health tech and life sciences sectors, focusing on anti-aging, cosmetics, and skin care for both B2B and B2C markets across regions including Europe, Japan, and Israel.
Strategic signal
In October 2020, Luminera Derm was acquired by Allergan Aesthetics, an AbbVie company. This acquisition indicates a strategic move by a major pharmaceutical player to expand its portfolio in the aesthetic medicine market, validating Luminera Derm's product innovation and market position in injectable beauty solutions.
Company Intelligence Q&A
- What was a significant corporate milestone for Luminera Derm?
- Luminera Derm was acquired by Allergan Aesthetics, an AbbVie company, in October 2020.
- What is Crystalys?
- Crystalys is a calcium hydroxyapatite-based injectable dermal filler developed by Luminera Derm to restore facial volume and natural contours by promoting natural collagen generation.
- What is HArmonyCa?
- HArmonyCa is an injectable product from Luminera Derm designed to restore facial volume and correct facial deficiencies by promoting the generation of natural endogenous collagen.
- What are Hydryalix and Hydryal?
- Hydryalix is a sterile, transparent, cross-linked hyaluronic acid injectable filler, while Hydryal is an injectable, non-cross-linked hyaluronic acid clear gel, both developed by Luminera Derm to enhance skin hydration and restore skin vitality.
- What standards do Luminera Derm's products comply with?
- All Luminera Derm products strictly comply with ISO9001 and ISO13485 standards.